Welcome to our dedicated page for Medical Prop SEC filings (Ticker: MPW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Medical Properties Trust, Inc. (NYSE: MPW) SEC filings page provides access to the company’s official regulatory disclosures as a self-advised real estate investment trust focused on net-leased hospital facilities. Formed in 2003 and incorporated in Maryland, Medical Properties Trust files reports and current disclosures with the U.S. Securities and Exchange Commission in connection with its common stock listed on the New York Stock Exchange under the symbol MPW.
Through this page, users can review key filings such as Form 10-K annual reports, which typically include detailed information on the company’s healthcare real estate portfolio, general acute, behavioral health and post-acute facilities, geographic exposure across the United States and international markets, capital structure, risk factors and management’s discussion and analysis. Form 10-Q quarterly reports provide interim updates on revenues from rent billed, straight-line rent, income from financing leases, interest and other income, as well as expenses, impairment charges, joint venture performance and balance sheet changes.
Investors can also examine Form 8-K current reports, where Medical Properties Trust discloses material events such as quarterly earnings releases, approval of a stock repurchase program, and other significant corporate actions. For example, Form 8-K filings in 2025 reference press releases announcing financial results for specific quarters and the authorization of a common stock repurchase program. In addition, filings may include exhibits with supplemental information packages and investor presentations.
Alongside traditional document access, this page highlights AI-powered tools that summarize lengthy filings, explain complex sections and surface important items such as changes in rent collections, impairment charges, financing transactions and capital allocation decisions. Users can quickly identify relevant sections of 10-Ks, 10-Qs and 8-Ks, and track how Medical Properties Trust reports on its hospital real estate portfolio, debt profile and shareholder-related actions over time.
Medical Properties Trust, Inc. filed an 8-K to detail upcoming branding changes. The company’s New York Stock Exchange stock ticker will change from “MPW” to “MPT”, with trading under the new symbol beginning on February 2, 2026. Its common stock will remain listed on the NYSE and the CUSIP number will stay the same, so only the trading symbol is changing. The company also confirmed the previously planned relocation of its headquarters within Alabama to 10500 Liberty Parkway, Birmingham, Alabama 35242. These updates were announced in a press release furnished as an exhibit.
Medical Properties Trust director Emily Webster Murphy reported a new equity grant. On January 8, 2026, she was awarded 30,303 shares of common stock at a price of $0.00 per share, increasing her holdings to 105,828 shares held directly after the transaction.
The grant is subject to a vesting schedule. According to the filing, these shares vest in equal installments at the beginning of each of 12 calendar quarters, starting on April 1, 2026, meaning the award will vest over a three-year period if service conditions are met.
Medical Properties Trust director receives stock-based award. Director Stewart Michael G reported an award of 30,303 shares of Medical Properties Trust common stock on January 8, 2026, at a stated price of $0 per share, indicating this is an equity compensation grant rather than an open-market purchase.
After this grant, he beneficially owns 187,403 shares in total. According to the filing, these granted shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, creating a multi-year vesting schedule that ties the award to ongoing service with the company.
Medical Properties Trust director reports stock award
Director Thompson C. Reynolds III reported receiving 30,303 shares of Medical Properties Trust common stock on January 8, 2026. The reported price of $0 per share indicates this was an equity award rather than an open-market purchase. Following this grant, he beneficially owns 108,795 shares, held directly.
The award is structured to vest over time. According to the filing, the shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, aligning director compensation with the company’s longer-term performance.
Medical Properties Trust, Inc. director Steven G. Dawson reported receiving 30,303 shares of common stock on January 8, 2026. The shares were acquired at a price of $0, indicating they are an equity award rather than an open-market purchase. After this grant, Dawson directly holds 194,520 shares of common stock.
According to the filing, these 30,303 shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026. In addition to his direct holdings, the report shows 10,000 shares held indirectly through his spouse's 401(k) and 13,138 shares held indirectly as trustee for the Dawson Interest Pension Plan.
Medical Properties Trust Inc. director Elizabeth N. Pitman reported acquiring 30,303 shares of the company’s common stock on January 8, 2026, at a price of $0 per share. These shares vest in equal installments at the beginning of each of the 12 calendar quarters starting April 1, 2026, meaning they will be earned gradually over three years. After this award, she beneficially owns 130,898 shares of Medical Properties Trust common stock held directly.
Medical Properties Trust (MPW) director Daniel Paul Sparks reported an equity award of 30,303 shares of common stock on January 8, 2026. The award was recorded at a price of $0 per share, indicating it is a stock-based compensation grant rather than an open‑market purchase.
After this grant, Sparks beneficially owns 150,546 shares of Medical Properties Trust common stock in direct form. According to the footnote, these shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, meaning the award will become fully vested over a three‑year period if service-based conditions are met.
Medical Properties Trust director Mozingo Caterina Ardon reported acquiring 30,303 shares of common stock on January 8, 2026 at a price of $0 per share, indicating a stock-based award rather than an open-market purchase. Following this transaction, she directly holds 110,468 shares of Medical Properties Trust common stock. According to the filing, these shares vest ratably at the beginning of each of the 12 calendar quarters starting on April 1, 2026, meaning the award is spread over three years of service.
Medical Properties Trust executive reports tax-related share withholding. SVP of Finance and Treasurer Charles R. Lambert had 2,836 shares of common stock withheld on January 9, 2026 at $5.04 per share in connection with the vesting of restricted stock, solely to cover tax obligations. According to the disclosure, this is not treated as a sale transaction. After this withholding, he beneficially owns 317,401 shares of Medical Properties Trust common stock directly.
Medical Properties Trust SVP of Operations Williams Rosa Handley reported an automatic share withholding tied to equity compensation. On January 9, 2026, 6,158 shares of common stock were withheld at $5.04 per share to cover tax obligations upon the vesting of restricted stock. The filing notes that this is not a sale transaction in the market. After this tax withholding event, Handley beneficially owned 389,024 shares of Medical Properties Trust common stock directly.
FAQ
What is the current stock price of Medical Prop (MPW)?
What is the market cap of Medical Prop (MPW)?
